CN Patent

CN101437490A — 稳定乳液配方

Assigned to Amgen Inc · Expires 2009-05-20 · 17y expired

What this patent protects

本发明涉及诸如拟钙剂(calcimimetics)的刺激剂的可注射配方，其在医药学上为稳定的且在注射后展示刺激、疼痛、静脉炎、沉淀和溶血的发生率降低。

USPTO Abstract

本发明涉及诸如拟钙剂(calcimimetics)的刺激剂的可注射配方，其在医药学上为稳定的且在注射后展示刺激、疼痛、静脉炎、沉淀和溶血的发生率降低。

Drugs covered by this patent

elacestrant-hydrochloride (ELACESTRANT HYDROCHLORIDE)

Patent Metadata

Patent number: CN101437490A
Jurisdiction: CN
Classification: —
Expires: 2009-05-20
Drug substance claim: No
Drug product claim: No
Assignee: Amgen Inc
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.